STOCK TITAN

Schwazze Sets Fourth Quarter and Full Year 2023 Conference Call for March 27, 2024 at 5:00 p.m. ET

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Schwazze, operating as Medicine Man Technologies, will host a conference call to discuss its financial and operational results for Q4 and FY 2023. The call will provide insights into the company's performance and future prospects.
Positive
  • None.
Negative
  • None.

DENVER, March 12, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, March 27, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the fourth quarter and full year ended December 31, 2023. The Company's results will be reported in a press release prior to the call.

The Schwazze management team will host the conference call, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call by emailing ir@schwazze.com.

Date: Wednesday, March 27, 2024
Time: 5:00 p.m. Eastern time
Toll-free dial-in: (888) 664-6383
International dial-in: (416) 764-8650
Conference ID: 38840334
Webcast: SHWZ Q4 & FY 2023 Earnings Call

The conference call will also be broadcast live and available for replay on the investor relations section of the Company's website at https://ir.schwazze.com.

Toll-free replay number: (888) 390-0541
International replay number: (416) 764-8677
Replay ID: 840334

If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.

About Schwazze

Schwazze (OTCQX: SHWZ) (Cboe: SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to take its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale.

Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company's leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector.

Medicine Man Technologies, Inc. was Schwazze's former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc. Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth. To learn more about Schwazze, visit http://www.schwazze.com/.

Investor Relations Contact

Sean Mansouri, CFA or Aaron D'Souza
Elevate IR
(720) 330-2829
ir@schwazze.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/schwazze-sets-fourth-quarter-and-full-year-2023-conference-call-for-march-27-2024-at-500-pm-et-302087190.html

SOURCE Schwazze

Schwazze will host the conference call on Wednesday, March 27, 2024, at 5:00 p.m. Eastern time.

Interested parties can submit questions to the Company prior to the call by emailing ir@schwazze.com.

The webcast for the Schwazze Q4 & FY 2023 Earnings Call can be accessed at https://ir.schwazze.com.

The toll-free replay number for the Schwazze conference call is (888) 390-0541, and the international replay number is (416) 764-8677.

In case of difficulty registering or connecting with the conference call, Elevate IR can be contacted at (720) 330-2829.
Medicine Man Technologies Inc

OTC:SHWZ

SHWZ Rankings

SHWZ Latest News

SHWZ Stock Data

Administrative Management and General Management Consulting Services
Professional, Scientific, and Technical Services
Professional, Scientific, and Technical Services, Process Industries, Administrative Management and General Management Consulting Services , Agricultural Commodities/Milling

About SHWZ

medicine man technologies, (symbol: mdcl), offers full service cannabis consulting and licensing of our state-of-the-art, turnkey cultivation and dispensary operating solutions. we represent and license the cultivation and dispensary ip of medicine man, a prominent tier iii colorado operator. we help clients navigate state applications, facility design, business and financial planning, as well as facilitate the adoption of operating procedures and training materials to teach your organization how to effectively operate a commercial cultivation and retail dispensary. we provide the experience and expertise to clients who have the resources necessary to enter the competitive medical and adult use cannabis marketplace, helping to mitigate the costly mistakes that many new companies will experience.